Literature DB >> 27604155

Molecular basis of antibody-mediated neutralization and protection against flavivirus.

Lianpan Dai1, Qihui Wang2,3, Jianxun Qi4, Yi Shi5,3,4,6,7, Jinghua Yan2,3,4,7, George F Gao8,9,10,11,12,13.   

Abstract

Antibody-mediated humoral immunity plays a pivotal role in flavivirus control. Neutralizing antibodies targeting viral envelope (E) protein, provide protection against flaviviruses in vivo but can also promote virus infection by antibody-dependent enhancement when antibodies are weakly neutralizing or in subneutralizing concentrations. The molecular basis for antibody-mediated virus neutralization can be revealed by structural studies of monoclonal antibodies complexed with the E protein or virion. In addition, the flavivirus non-structural protein NS1 can also induce host antibody production, and some of these antibodies can provide protection against virus challenge. In this review, we summarize the known structures of flavivirus neutralizing or protective antibodies bound to their epitopes and describe the underlying molecular mechanisms.
© 2016 IUBMB Life, 68(10):783-791, 2016. © 2016 International Union of Biochemistry and Molecular Biology.

Entities:  

Keywords:  antibodies; flavivirus; neutralization; protection; structural basis

Mesh:

Substances:

Year:  2016        PMID: 27604155     DOI: 10.1002/iub.1556

Source DB:  PubMed          Journal:  IUBMB Life        ISSN: 1521-6543            Impact factor:   3.885


  22 in total

1.  Molecular Basis of a Protective/Neutralizing Monoclonal Antibody Targeting Envelope Proteins of both Tick-Borne Encephalitis Virus and Louping Ill Virus.

Authors:  Xu Yang; Jianxun Qi; Ruchao Peng; Lianpan Dai; Ernest A Gould; George F Gao; Po Tien
Journal:  J Virol       Date:  2019-04-03       Impact factor: 5.103

2.  Basic Amino Acid Substitution at Residue 367 of the Envelope Protein of Tembusu Virus Plays a Critical Role in Pathogenesis.

Authors:  Mengxu Sun; Lijiao Zhang; Yanxin Cao; Jun Wang; Ziding Yu; Xue Sun; Fengli Liu; Zhuolin Li; Pinghuang Liu; Jingliang Su
Journal:  J Virol       Date:  2020-03-31       Impact factor: 5.103

Review 3.  Mapping the diverse structural landscape of the flavivirus antibody repertoire.

Authors:  Madhumati Sevvana; Richard J Kuhn
Journal:  Curr Opin Virol       Date:  2020-08-13       Impact factor: 7.090

4.  Recombinant Chimpanzee Adenovirus Vaccine AdC7-M/E Protects against Zika Virus Infection and Testis Damage.

Authors:  Kun Xu; Yufeng Song; Lianpan Dai; Yongli Zhang; Xuancheng Lu; Yijia Xie; Hangjie Zhang; Tao Cheng; Qihui Wang; Qingrui Huang; Yuhai Bi; William J Liu; Wenjun Liu; Xiangdong Li; Chuan Qin; Yi Shi; Jinghua Yan; Dongming Zhou; George F Gao
Journal:  J Virol       Date:  2018-02-26       Impact factor: 5.103

5.  Enhancement of Zika virus pathogenesis by preexisting antiflavivirus immunity.

Authors:  Susana V Bardina; Paul Bunduc; Shashank Tripathi; James Duehr; Justin J Frere; Julia A Brown; Raffael Nachbagauer; Gregory A Foster; David Krysztof; Domenico Tortorella; Susan L Stramer; Adolfo García-Sastre; Florian Krammer; Jean K Lim
Journal:  Science       Date:  2017-03-30       Impact factor: 47.728

6.  Physiological temperatures reduce dimerization of dengue and Zika virus recombinant envelope proteins.

Authors:  Stephan T Kudlacek; Lakshmanane Premkumar; Stefan W Metz; Ashutosh Tripathy; Andrey A Bobkov; Alexander Matthew Payne; Stephen Graham; James A Brackbill; Michael J Miley; Aravinda M de Silva; Brian Kuhlman
Journal:  J Biol Chem       Date:  2018-04-20       Impact factor: 5.157

Review 7.  Complexity of Viral Epitope Surfaces as Evasive Targets for Vaccines and Therapeutic Antibodies.

Authors:  Nathaniel L Miller; Rahul Raman; Thomas Clark; Ram Sasisekharan
Journal:  Front Immunol       Date:  2022-06-17       Impact factor: 8.786

Review 8.  Vaccination strategies against Zika virus.

Authors:  Estefania Fernandez; Michael S Diamond
Journal:  Curr Opin Virol       Date:  2017-04-19       Impact factor: 7.090

Review 9.  Monoclonal Antibodies against Zika Virus: Therapeutics and Their Implications for Vaccine Design.

Authors:  Qihui Wang; Jinghua Yan; George Fu Gao
Journal:  J Virol       Date:  2017-09-27       Impact factor: 5.103

10.  Refocusing the Immune Response to Selected Epitopes on a Zika Virus Protein Antigen by Nanopatterning.

Authors:  Ana Castro; Juan Manuel Carreño; James Duehr; Florian Krammer; Ravi S Kane
Journal:  Adv Healthc Mater       Date:  2021-04-30       Impact factor: 11.092

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.